How inflammasomes affect the removal of axons in neurons
Unexpected Function of Inflammasomes in Axon Pruning: Focus on NLRP1
['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-11045039
This study is looking at how certain proteins in the brain help neurons trim their connections, which is important for keeping the brain healthy, especially in conditions like Alzheimer's Disease, and it hopes to find new ways to help treat these kinds of illnesses.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-11045039 on ClinicalTrials.gov |
What this research studies
This research investigates the role of inflammasomes in the process of axon pruning, which is crucial for maintaining healthy neuronal connections. By using a specialized microfluidic chamber model, the researchers are examining how neurons can selectively degenerate their axons rather than the entire cell, particularly in the context of Alzheimer's Disease. The study aims to uncover the mechanisms behind this process, focusing on the activation of specific pathways and proteins involved in axon pruning. Understanding these mechanisms could provide insights into neurodegenerative diseases and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing symptoms of Alzheimer's Disease or related neurodegenerative conditions.
Not a fit: Patients who are not affected by neurodegenerative diseases or are under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating or preventing Alzheimer's Disease by targeting the mechanisms of axon pruning.
How similar studies have performed: Previous research has shown that understanding cellular mechanisms in neurodegeneration can lead to significant advancements in treatment, suggesting this approach has potential for success.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DESHMUKH, MOHANISH P — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: DESHMUKH, MOHANISH P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome